Clinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX) for active left-sided ulcerative colitis.
Celasco, G
Clinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX) for active left-sided ulcerative colitis. [electronic resource] - Alimentary pharmacology & therapeutics Feb 2010 - 375-86 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
1365-2036
10.1111/j.1365-2036.2009.04194.x doi
Administration, Oral
Adolescent
Adult
Aged
Anticoagulants--administration & dosage
Colitis, Ulcerative--drug therapy
Colon--drug effects
Delayed-Action Preparations
Dose-Response Relationship, Drug
Double-Blind Method
Female
Heparin, Low-Molecular-Weight--administration & dosage
Humans
Male
Middle Aged
Treatment Outcome
Young Adult
Clinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX) for active left-sided ulcerative colitis. [electronic resource] - Alimentary pharmacology & therapeutics Feb 2010 - 375-86 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
1365-2036
10.1111/j.1365-2036.2009.04194.x doi
Administration, Oral
Adolescent
Adult
Aged
Anticoagulants--administration & dosage
Colitis, Ulcerative--drug therapy
Colon--drug effects
Delayed-Action Preparations
Dose-Response Relationship, Drug
Double-Blind Method
Female
Heparin, Low-Molecular-Weight--administration & dosage
Humans
Male
Middle Aged
Treatment Outcome
Young Adult